Serabelisib (MLN1117, INK1117, TAK-117) CAS# 1268454-23-4
Serabelisib (MLN1117, INK1117, TAK-117)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-3021 | 100mg | 520.00 | + Add to cart |
|
| R-C-3021 | 200mg | 920.00 | + Add to cart |
|
| R-C-3021 | 500mg | 1650.00 | + Add to cart |
|
|
|
||||
Product description
PI3K alpha inhibitor INK1117 selectively inhibits PI3K alpha kinase, including mutations of PIK3CA, in the PI3K/Akt/mTOR pathway,which may result in tumor cell apoptosis and growth inhibition in PI3K alpha-expressing tumor cells. Only for scientific research, not for human body.
| Appearance | N/A |
|---|---|
| Molecular weight | N/A |
| purity | >95% |
| Solubility | N/A |
| Cas | 1268454-23-4 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---Serabelisib (MLN1117, INK1117, TAK-117)
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


